TAVR sales were up 9% for Edwards in Street-beating Q2 : vim

Edwards Lifesciences (NYSE: EW) shares fell after hours today despite second-quarter results that beat the consensus forecast.

Related Keywords

Irvine , California , United States , Massdevice Medtech , Bernard Zovighian , , Edwards Lifesciences , Wall Street , Pascal Precision ,